Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-19-020744)

Filing Details

Accession Number:: 0001437749-19-020744
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-10-28 16:29:26
Reporting Period:: 2019-06-10

Accepted Time:: 2019-10-28 16:29:26
Original Submission Date:: 2019-06-12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389545	Novabay Pharmaceuticals Inc.	NBY	Pharmaceutical Preparations (2834)	680454536

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1663021	Justin Hall	C/O Novabay Pharmaceuticals, Inc. 2000 Powell Street, Suite 1150 Emeryville CA 94608	Interim President & Ceo And Gc	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-06-10	47,500	$2.02	50,905	No	4	A	Direct
Common Stock	Disposition	2019-06-10	47,500	$3.03	3,405	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-06-10	47,500	$0.00	47,500	$2.02

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2019-05-31	2028-05-31	No	4	X	Direct

Footnotes

The amended Form 4 is being filed to show (1) the corresponding acquisition of common stock after the exercise of options in Table I and (2) the immediate sale of common stock after such exercise of options in Table I.